GlassScriptPhysician profile
David Northcutt
NPI 1922235340
$2,466.06
in general payments reported to CMS, 2019-2025
20 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,323 · 2020: $22.95 · 2021: $38.89 · 2022: $762 · 2023: $41.78 · 2024: $104 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,115.00 | 2019 | |
| Treace Medical Concepts, INC. | $786.14 | 2022-2023 | |
| Melinta Therapeutics, LLC | $120.52 | 2019 | |
| Stryker Corporation | $72.35 | 2024-2025 | Ortholoc 2 Lapifuse, Easyfuse |
| Smith+Nephew, INC. | $53.94 | 2019-2025 | Collagenase Santyl |
| Globus Medical, INC. | $32.67 | 2025 | Senza |
| Depuy Synthes Sales INC. | $29.97 | 2024 | Healix Knotless Peek, Dynatape |
| Kerecis Limited | $26.80 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Mf Med | $24.97 | 2025 | |
| Orthofix Medical, INC. | $22.95 | 2020 | |
| Abbott Laboratories | $21.54 | 2019 | |
| Djo, LLC | $20.74 | 2019 | |
| Averitas Pharma INC. | $20.58 | 2025 | Qutenza |
| Boston Scientific Corporation | $18.84 | 2024 | Wavewriter Alpha Prime 16 |
| Paratek Pharmaceuticals, INC. | $18.33 | 2024 | Nuzyra |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $17.59 | 2022 | |
| Integra Lifesciences Corporation | $17.52 | 2021 | |
| Normatec Industries, LP | $16.32 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $15.73 | 2025 | |
| Tactile Systems Technology INC | $13.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Northcutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.